Pharmacists in Rutherford College, NC Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Nickolas Sprinkle, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Us-70, Rutherford College, NC 28671 Phone: 828-874-2119 |
Dr. Jeffrey Van Clontz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Us 70, Rutherford College, NC 28671 Phone: 828-874-2119 |
 Dr. Kristy Perry Guillen, PHARMD, CPP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 722 Malcolm Boulevard, Rutherford College, NC 28671 Phone: 828-580-7955 Fax: 828-580-7953 |
Kelly Hartman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 722 Malcolm Blvd, Rutherford College, NC 28671 Phone: 828-580-7549 |
News Archive
Study: Vitamin D can reduce side effects associated with chemotherapy
As many cancer patients will confirm, the chemotherapy prescribed to kill the disease is often more debilitating than the cancer itself, with a range of horrendous side effects.
Adequate parent-child relationship may offer protection against all chronic illnesses in later life
Growing up in a well-off home can benefit a child's physical health even decades later — but a lack of parent-child warmth, or the presence of abuse, may eliminate the health advantage of a privileged background, according to a Baylor University study.
Diet high in fibre may ward off asthma
The Western diet probably has more to do with the asthma epidemic than has been assumed so far because developing asthma is related to the amount of fruit and vegetables consumed. Gut bacteria ferment the dietary fibres contained in them and fatty acids enter the blood as a result, influencing the immune response in the lungs. This has been shown by a research project funded by the Swiss National Science Foundation (SNSF).
PD-L1 protein could be a potential immunotherapy target for malignant pleural mesothelioma
Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to data from a prospective randomized phase II trial presented at ESMO 2014 Congress in Madrid.
› Verified 2 days ago